Molecular Templates, Inc. (MTEM)
NASDAQ: MTEM · IEX Real-Time Price · USD
1.650
+0.010 (0.61%)
At close: May 1, 2024, 4:00 PM
1.720
+0.070 (4.24%)
After-hours: May 1, 2024, 5:25 PM EDT

Molecular Templates Revenue

In the year 2023, Molecular Templates had annual revenue of $57.31M with 190.10% growth. Revenue in the quarter ending December 31, 2023 was $7.02M with 168.71% year-over-year growth.

Revenue (ttm)
$57.31M
Revenue Growth
+190.10%
P/S Ratio
0.15
Revenue / Employee
$924,290
Employees
62
Market Cap
8.87M USD

Revenue Chart

History

Fiscal Year End Revenue Change Growth
Dec 31, 202357.31M37.55M190.10%
Dec 31, 202219.75M-18.94M-48.95%
Dec 31, 202138.70M19.85M105.34%
Dec 31, 202018.85M-3.43M-15.38%
Dec 31, 201922.27M8.99M67.63%
Dec 31, 201813.29M9.89M291.31%
Dec 31, 20173.40M1.52M80.59%
Dec 31, 20161.88M-75.04M-97.56%
Dec 31, 201576.92M62.19M422.45%
Dec 31, 201414.72M2.23M17.82%
Dec 31, 201312.50M6.63M112.97%
Dec 31, 20125.87M5.81M9,362.90%
Dec 31, 201162.00K--
Dec 31, 20100--
Dec 31, 20090--
Dec 31, 20081.44M4.00K0.28%
Dec 31, 20071.44M-25.00K-1.71%
Dec 31, 20061.46M771.00K111.74%
Dec 31, 2005690.00K--
Dec 31, 20040--
Dec 31, 20030--
Dec 31, 20020--
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name Revenue
Biofrontera 34.07M
TRxADE HEALTH 8.27M
NeuroMetrix 5.90M
Aeterna Zentaris 4.50M
Vaccinex 570.00K
Inhibikase Therapeutics 260.50K
BioRestorative Therapies 145.80K
Revenue Rankings